
Currently out of the existing stock ratings of Simos Simeonidis, 36 are a BUY (78.26%), 10 are a HOLD (21.74%).
Analyst Simos Simeonidis, has had 70.17% of price targets met with an average potential upside of 34.98%, reached in 652 days on average. Previously, Simos Simeonidis worked at RBC.
Simos Simeonidis has documented 85 price targets and ratings displayed on 12 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on INCY, yte at 04-Apr-2017.
Analyst best performing recommendations are on DVAX (DYNAVAX TECHNOLOGIES).
The best stock recommendation documented was for DVAX (DYNAVAX TECHNOLOGIES) on 4/27/2016. The price target of $17 was fulfilled within 2 days with a profit of $1.53 (8.26%), with a performance score of 41.28.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Jul-2017
$205
5 years 6 months 16 days ago
(05-May-2021)
3/5 (60%)
$35.09 (20.65%)
938
Hold Since 03-May-2021
$173
$156
5 years 6 months 18 days ago
(03-May-2021)
18/29 (62.07%)
$2.73 (1.60%)
667
Buy Since 08-Feb-2018
$166
$179
5 years 9 months 17 days ago
(04-Feb-2021)
21/21 (100%)
$10.41 (6.69%)
711
Hold Since 04-Feb-2021
$190
$194
5 years 9 months 17 days ago
(04-Feb-2021)
13/15 (86.67%)
$34.41 (22.12%)
458
Buy Since 06-Sep-2019
$175
$165
5 years 9 months 17 days ago
(04-Feb-2021)
3/3 (100%)
$19.41 (12.48%)
397
Stocks Simos Simeonidis covered previously. Scores are shown for active stocks only.
The record of these past calls is part of the data set at anachart.store.